Form 4 for BCYC BICYCLE THERAPEUTICS PLC
Accepted 2023-01-05 00:00:00 ET · period of report 2023-01-03 · accession 0001209191-23-002178 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-01-05 | 2023-01-03 | BCYC | Lee Kevin | CEO, Dir | S - Sale | $29.06 | -6,000 | 326.6K | -2% | -$174.4K |
| D | 2023-01-05 | 2023-01-03 | BCYC | Lee Kevin | CEO, Dir | A - Grant | $0.00 | +57.5K | 332.6K | +21% | $0 |
| D | 2023-01-05 | 2023-01-03 | BCYC | Lee Kevin | CEO, Dir | A - Grant | $0.00 | +115.0K | 115.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2023-01-03 | S | D | 6,000 | $29.06 | 326,585 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.00 to $29.545 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 2 | Common | Ordinary Shares | 2023-01-03 | A | A | 57,500 | $0.00 | 332,585 | D | — | — | (F1) Represents a restricted stock unit ("RSU") award. One-fourth (1/4) of the total number of RSUs shall vest on January 3, 2024 and the remaining RSUs shall vest in 12 equal quarterly installments thereafter. (F2) Each RSU represents a contingent right to receive one ordinary share. |
| 3 | Derivative | Employee Stock Option (right to buy) | 2023-01-03 | A | A | 115,000 | $0.00 | 115,000 | D | $29.60 · — to 2033-01-03 | 115,000 Ordinary Shares | (F5) This option shall vest one-fourth (1/4) of the total number of shares underlying the option on January 3, 2024 and the remaining shares in 36 equal monthly installments thereafter. |